LATEST ALERTS
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has begun the process of collecting data and evaluating the risk posed by hexahydrocannabinol (HHC) and other semi-synthetic cannabinoids
The United Nations may be growing more accepting of a global legal cannabinoid sector, but it does not believe many countries have the capacity to successfully regulate such markets
The sale and possession of CBD will be banned in Hong Kong from the beginning of February 2023 following an announcement earlier this year. Under the new rules, CBD will be classified in the same way as heroin and cocaine
This report provides a detailed overview of the current regulatory framework in place for CBD, hemp and cannabis, covering all policy areas
This snapshot of Germany’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
This snapshot of Spain’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
The cannabinoid vape compliance database goes beyond the legality of cannabinoid-containing vaping products and provides regulatory information on how they can reach the market and thrive
This snapshot of the Netherland’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
CannIntelligence’s directory of stakeholders in the global cannabis sector allows you to find the most relevant organisations in key markets, with full web, email, phone and address details.
This snapshot of France’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
Members of the Mexican cannabis sector have told CannIntelligence they are pessimistic about whether the framework to regulate the national medical cannabis industry will be implemented before 2024
Tilray Brands continues to show signs of confidence in the future of cannabis-infused drinks by adding more beverage firms to its portfolio and building a distribution network
This report provides a detailed overview of the current regulatory framework in place in Lebanon for hemp, cannabinoids such as CBD, and cannabis
The predicted Red Wave never arrived – but how have the prospects for cannabis-related federal legislation in the US been changed by the midterm elections? US correspondent James DeLise considers the new balance of power in Washington
A cannabis regulation lawyer believes the UK Food Standards Agency (FSA) and the CBD sector have invested so much time, effort and money in the novel food process that it cannot be allowed to fail
In an exclusive partnership with Charlotte’s Web, Major League Baseball (MLB) has become the first of the major US sports leagues to sign a deal with a cannabinoid company
Nearly six months after the European Food Safety Authority (Efsa) put novel food assessments for cannabinoids on hold, none of the validated applicants has been able to fill the identified knowledge gaps
Sweden’s general election in September was not good news for cannabis advocates, with the new right-wing bloc minority government likely to take a highly restrictive view, while cannabinoids are not high on its agenda
The US Food and Drug Administration (FDA) recently appointed Norman Birenbaum to a top post as a senior public health adviser in the FDA’s Center for Regulatory Programs, signalling a seismic shift at the agency
This report provides a detailed overview of the current regulatory framework in place in the Netherlands for hemp, cannabinoids such as CBD and cannabis
US tobacco company 22nd Century Group has enjoyed its first full quarter benefitting from revenue generated by its new hemp/cannabis business arm
Legal hurdles impeding recreational cannabis legalisation in Mexico are expected to continue through 2024, industry members told CannIntelligence during the CannaMexico conference last month
German hemp supplier Signature Products is taking a step back to its roots, saying it will step up its marketing of Ccell vape devices that can be filled with CBD extracts
Austria’s almost non-existent regime for the use of cannabinoids in medication has been described as “a Kafkaesque nightmare” with over-officious bureaucracy putting pointless hurdles in patients’ way
Amazon still seems to be laissez-faire about enforcement of ingestible hemp-derived cannabinoid products that appear on its site – and in particular those containing intoxicating hemp-derived cannabinoids (IHDCs)
The UK Advertising Standards Authority (ASA) has taken action on CBD product marketing, targeting a series of advertorials produced by Consumer Logic Research specifically promoting two brands
Hemp products are sometimes regulated in Europe as a product made of herbs and plants that is intended for smoking. This report examines the the regulatory framework for relevant policy areas in selected countries
The UK is lagging behind other major markets in the world on research into the benefits of medicinal cannabis, according to a scientist specialising in the area
US president Joe Biden has called for a scheduling review of cannabis. This report will examine the procedure, potential outcomes, and implications of this scheduling review.
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
